101 related articles for article (PubMed ID: 4114679)
1. Preclinical toxicologic evaluation of bleomycin (NSC 125 066), a new antitumor antibiotic.
Thompson GR; Baker JR; Fleischman RW; Rosenkrantz H; Schaeppi UH; Cooney DA; Davis RD
Toxicol Appl Pharmacol; 1972 Aug; 22(4):544-55. PubMed ID: 4114679
[No Abstract] [Full Text] [Related]
2. Bleomycin-induced interstitial pneumonia in dogs.
Fleischman RW; Baker JR; Thompson GR; Schaeppi UH; Illievski VR; Cooney DA; Davis RD
Thorax; 1971 Nov; 26(6):675-82. PubMed ID: 4111464
[TBL] [Abstract][Full Text] [Related]
3. Preclinical toxicologic evaluation of bleomycin (NSC-125066) in rhesus monkeys.
Schaeppi U; Thompson GR; Fleischman RW; Baker JR; Rosenkrantz H; Ilievski V; Cooney DA; Davis RD
Cancer Chemother Rep 3; 1973 Jan; 4(1):31-9. PubMed ID: 4123233
[No Abstract] [Full Text] [Related]
4. Bleomycin-induced pulmonary fibrosis: correlation of biochemical, physiological, and histological changes.
Hesterberg TW; Gerriets JE; Reiser KM; Jackson AC; Cross CE; Last JA
Toxicol Appl Pharmacol; 1981 Sep; 60(2):360-7. PubMed ID: 6169174
[No Abstract] [Full Text] [Related]
5. Cutaneous toxicity of bleomycin therapy.
Cohen IS; Mosher MB; O'Keefe EJ; Klaus SN; De Conti RC
Arch Dermatol; 1973 Apr; 107(4):553-5. PubMed ID: 4121404
[No Abstract] [Full Text] [Related]
6. Pulmonary fibrosis following multiple treatment with bleomycin (NSC-125066) in dogs.
Schaeppi U; Phelan R; Stadnicki SW; Fleischman RW; Heyman IA; Ilievski V; Redding RA
Cancer Chemother Rep; 1974; 58(3):301-10. PubMed ID: 4135459
[No Abstract] [Full Text] [Related]
7. [Toxicity test of bleomycin oil suspension. Chronic toxicity in beagle dogs (author's transl].
Ito K; Handa J; Mori M; Ezura H; Kumagai M; Suzuki A; Nakabayashi Y; Irie Y; Yamashita T; Miyamoto K; Tsubosaki M; Matsuda A; Konoha N
Jpn J Antibiot; 1980 Jan; 33(1):29-72. PubMed ID: 6154813
[No Abstract] [Full Text] [Related]
8. Mouse models of bleomycin-induced pulmonary fibrosis.
Walters DM; Kleeberger SR
Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.46. PubMed ID: 22294226
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the production and prevention of lung diseases observed during treatment with bleomycin].
Flandre O; Beaulaton IS; Damon M; Allieu M
Therapie; 1972; 27(1):67-76. PubMed ID: 4111716
[No Abstract] [Full Text] [Related]
10. [Toxicological studies on pepleomycin sulfate (NK631). VI. Chronic toxicity of pepleomycin in dogs (author's transl)].
Ito K; Handa J; Irie Y; Ezura H; Kumagai M; Irie Y; Suzuki A; Hagiwara T; Yamane H; Miyamoto K; Yamashita T; Tsubosaki M; Matsuda A; Konoha N
Jpn J Antibiot; 1979 Mar; 32(3):387-450. PubMed ID: 86626
[TBL] [Abstract][Full Text] [Related]
11. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
13. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Nici L; Santos-Moore A; Kuhn C; Calabresi P
Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
[TBL] [Abstract][Full Text] [Related]
14. Toxicological studies on (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Its chronic toxicity in beagle dogs.
Kurebe M; Yokota M; Chesterman H; Massey JE; Gopinath C; Heywood R
Jpn J Antibiot; 1986 Feb; 39(2):429-61. PubMed ID: 3712752
[No Abstract] [Full Text] [Related]
15. Enhancement of antioxidant defense system by epigallocatechin-3-gallate during bleomycin induced experimental pulmonary fibrosis.
Sriram N; Kalayarasan S; Sudhandiran G
Biol Pharm Bull; 2008 Jul; 31(7):1306-11. PubMed ID: 18591765
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol alleviates bleomycin-induced lung injury in rats.
Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary toxicity of antitumor agents.
Muggia FM; Louie AC; Sikic BI
Cancer Treat Rev; 1983 Dec; 10(4):221-43. PubMed ID: 6198083
[No Abstract] [Full Text] [Related]
18. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis.
Kato S; Inui N; Hakamata A; Suzuki Y; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
Respir Res; 2018 Jun; 19(1):127. PubMed ID: 29940932
[TBL] [Abstract][Full Text] [Related]
19. [Bleomycin. A preliminary report on a new antitumor antibiotic].
Rygård J; Hansen HS; Jensen KB; Aastrup J; Jorgensen SJ; Blichert-Toft M; Floystrup T; Gerlith A
Ugeskr Laeger; 1971 Feb; 133(8):335-42. PubMed ID: 5546963
[No Abstract] [Full Text] [Related]
20. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
